Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MUMO-1 by Esteve Pharmaceuticals for Unspecified Pain: Likelihood of Approval
MUMO-1 is under clinical development by Esteve Pharmaceuticals and currently in Phase I for Unspecified Pain. According to GlobalData, Phase...